Parkinson's Disease Trial, Recruiting NCT04179695 Sponsor: University Hospital, Lille Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT04179695
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults (men and women) who have been diagnosed with Parkinson's disease, at any stage of the condition
  • People who do not have a severe long-term neurological, mental, or psychiatric condition
  • People who do not have significant memory or thinking difficulties that affect their daily independence (assessed using standard medical criteria and a cognitive screening test)
  • People who are able to attend appointments, either on their own or with someone accompanying them
  • People who are enrolled in the French social security system
  • People who have signed a form agreeing to take part in the study
  • People who are willing to follow all study procedures for the full duration of the trial

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People for whom it is not possible to receive or understand information about the study, who cannot commit to the full duration of the trial, who are not covered by the French social security system, or who do not wish to sign the consent form
  • People who are under legal guardianship or a similar form of legal protection (confirm with trial site)
  • People who are not sufficiently fluent in French to understand the instructions needed to complete the cognitive tests used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Devos, University Hospital, Lille

Phone: 03 20 44 54 49

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 July 2020
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

variation of the delta of G-MISS Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov